Lam Research Corporation vs Zimmer Biomet Holdings Inc — how do they compare? Lam Research Corporation trades at $323.02 (market cap $383.63B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Lam Research Corporation is far larger — about 22.1× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.07%). Which is the better fit depends on your goals.
| LRCX | ZBH | |
|---|---|---|
Market Cap | $383.63B | $17.36B |
Sector | Technology | Health |
52-Week High | $433.33 | $107.71 |
52-Week Low | $94.84 | $79.58 |
Enterprise Value | $382.61B | $24.40B |
Dividend Yield | 0.34% | 1.07% |
Trailing returns across standard periods
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →